Optometrists in Stevens Point, WI Accepting Medicare

11 Optometrists found. Showing 1 - 11

Ira Gail Altaras, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 316 Division St, Stevens Point, WI 54481 Phone: 715-344-5355

Dr. Stephen Ray Rollins, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 200 Division St, Stevens Point, WI 54481 Phone: 715-341-0198    Fax: 715-343-8255

Sterling Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 200 Division St, Stevens Point, WI 54481 Phone: 715-341-0198

Sterling Optical Optometrist Medicare: Medicare Enrolled Practice Location: 2212 Division St, Stevens Point, WI 54481 Phone: 715-341-0198

Marge Lynne Lebrick, MSED, CVRT Optometrist - Vision Therapy Medicare: Not Enrolled in Medicare Practice Location: 3262 Church St, Stevens Point, WI 54481 Phone: 715-344-4010

Amanda B Hoffmann, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3401 Stanley St, Stevens Point, WI 54481 Phone: 715-261-8500    Fax: 715-261-8667

Brad W. Christopherson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4100 State Hwy 66, Stevens Point, WI 54482 Phone: 715-343-7760

Kimberly K Rutkowski, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 316 Division St, Stevens Point, WI 54481 Phone: 715-344-5355    Fax: 715-344-1798

Ronald Kuehl, Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1324 Centerpoint Dr, Stevens Point, WI 54481 Phone: 715-341-5088

Dr. Ashley Ozanne, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Division St, Stevens Point, WI 54481 Phone: 715-341-0198

Dr. Ronald Clyde Kuehl, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1324 Centerpoint Dr, Stevens Point, WI 54481 Phone: 715-341-5088    Fax: 715-341-5094

News Archive

MHRA approves first monoclonal antibody treatment for COVID-19 in the UK

Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on Human Medicines (CHM), the government's independent expert scientific advisory body, the MHRA has approved Ronapreve as the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID-19 infection for the UK.

Designer compound may be effective tool for tackling tau-related disorders

In a study of mice and monkeys, National Institutes of Health funded researchers showed that they could prevent and reverse some of the brain injury caused by the toxic form of a protein called tau.

Global health is recurrently being threatened by new and re-emerging infectious diseases

Global health is recurrently being threatened by new and re-emerging infectious diseases. Examples of new and re-emerging infectious diseases include SARS (Severe Acute Respiratory Syndrome), new variant CJD (Creutzfeldt-Jakob Disease), avian flu and Ebola.

Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

Celgene Global Health, a division of Celgene Corporation, and the Drugs for Neglected Diseases initiative strengthen their collaboration with a four-year Research Collaboration Agreement to identify and optimize new drug candidates for the treatment of neglected tropical diseases (NTDs).

Read more Medical News

› Verified 3 days ago